Pricing medicines: theory and practice, challenges and opportunities

Pricing medicines: theory and practice, challenges and opportunities

The pricing of medicines has become one of the most hotly debated topics of recent times, with the pharmaceutical industry seemingly being attacked from all quarters. From a company perspective, determining the price for each new product is more crucial than ever, given the present dearth of new dru...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature reviews. Drug discovery 2005-02, Vol.4 (2), p.121-130
Hauptverfasser: Gregson, Nigel, Sparrowhawk, Keiron, Mauskopf, Josephine, Paul, John
Format: Artikel
Sprache:eng
Schlagworte:
Costs and Cost Analysis - economics
Costs and Cost Analysis - methods
Costs and Cost Analysis - trends
Drug Costs - trends
Drug Industry - economics
Drug Industry - trends
Economics, Pharmaceutical - trends
Humans
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 130
container_issue 2
container_start_page 121
container_title Nature reviews. Drug discovery
container_volume 4
creator Gregson, Nigel
Sparrowhawk, Keiron
Mauskopf, Josephine
Paul, John
description The pricing of medicines has become one of the most hotly debated topics of recent times, with the pharmaceutical industry seemingly being attacked from all quarters. From a company perspective, determining the price for each new product is more crucial than ever, given the present dearth of new drug introductions. But how are pricing strategies developed in practice? What is value-based pricing and how are financial models of return on investment constructed? What are the challenges faced in setting the price for a particular product, and how will scientific and environmental trends provide future pricing challenges or opportunities?
doi_str_mv 10.1038/nrd1633
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67400792</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67400792</sourcerecordid><originalsourceid>FETCH-LOGICAL-c341t-b51919e08c02bd181938e535c104418aaf6561ff808c8f418e4bd3be7bdfd9843</originalsourceid><addsrcrecordid>eNpFkD1PwzAURS0EoqUg_gHKBAsBv9qxHTZUPqVKMMAcOfZza5QmwU6G_ntSGsH0rt49usMh5BzoDVCmbutgQTB2QKbAJU9BKn74l6WYkJMYvygFAXJ-TCaQCaWoFFPy8B688fUq2aDdBYx3SbfGJmwTXdukDdp03uB1Yta6qrBeYfwtmrZtQtfXvvMYT8mR01XEs_HOyOfT48fiJV2-Pb8u7pepYRy6tMwghxypMnReWlCQM4UZywxQzkFp7UQmwDk1EMoNH-SlZSXK0jqbK85m5HK_24bmu8fYFRsfDVaVrrHpYyEkp1Tm8wG82oMmNDEGdEUb_EaHbQG02AkrRmEDeTFO9uWg4J8bDbEfVDBlzw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67400792</pqid></control><display><type>article</type><title>Pricing medicines: theory and practice, challenges and opportunities</title><source>MEDLINE</source><source>Nature</source><source>SpringerLink Journals - AutoHoldings</source><creator>Gregson, Nigel ; Sparrowhawk, Keiron ; Mauskopf, Josephine ; Paul, John</creator><creatorcontrib>Gregson, Nigel ; Sparrowhawk, Keiron ; Mauskopf, Josephine ; Paul, John</creatorcontrib><description>The pricing of medicines has become one of the most hotly debated topics of recent times, with the pharmaceutical industry seemingly being attacked from all quarters. From a company perspective, determining the price for each new product is more crucial than ever, given the present dearth of new drug introductions. But how are pricing strategies developed in practice? What is value-based pricing and how are financial models of return on investment constructed? What are the challenges faced in setting the price for a particular product, and how will scientific and environmental trends provide future pricing challenges or opportunities?</description><identifier>ISSN: 1474-1776</identifier><identifier>EISSN: 1474-1784</identifier><identifier>DOI: 10.1038/nrd1633</identifier><identifier>PMID: 15688076</identifier><language>eng</language><publisher>England</publisher><subject>Costs and Cost Analysis - economics ; Costs and Cost Analysis - methods ; Costs and Cost Analysis - trends ; Drug Costs - trends ; Drug Industry - economics ; Drug Industry - trends ; Economics, Pharmaceutical - trends ; Humans</subject><ispartof>Nature reviews. Drug discovery, 2005-02, Vol.4 (2), p.121-130</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c341t-b51919e08c02bd181938e535c104418aaf6561ff808c8f418e4bd3be7bdfd9843</citedby><cites>FETCH-LOGICAL-c341t-b51919e08c02bd181938e535c104418aaf6561ff808c8f418e4bd3be7bdfd9843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15688076$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gregson, Nigel</creatorcontrib><creatorcontrib>Sparrowhawk, Keiron</creatorcontrib><creatorcontrib>Mauskopf, Josephine</creatorcontrib><creatorcontrib>Paul, John</creatorcontrib><title>Pricing medicines: theory and practice, challenges and opportunities</title><title>Nature reviews. Drug discovery</title><addtitle>Nat Rev Drug Discov</addtitle><description>The pricing of medicines has become one of the most hotly debated topics of recent times, with the pharmaceutical industry seemingly being attacked from all quarters. From a company perspective, determining the price for each new product is more crucial than ever, given the present dearth of new drug introductions. But how are pricing strategies developed in practice? What is value-based pricing and how are financial models of return on investment constructed? What are the challenges faced in setting the price for a particular product, and how will scientific and environmental trends provide future pricing challenges or opportunities?</description><subject>Costs and Cost Analysis - economics</subject><subject>Costs and Cost Analysis - methods</subject><subject>Costs and Cost Analysis - trends</subject><subject>Drug Costs - trends</subject><subject>Drug Industry - economics</subject><subject>Drug Industry - trends</subject><subject>Economics, Pharmaceutical - trends</subject><subject>Humans</subject><issn>1474-1776</issn><issn>1474-1784</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkD1PwzAURS0EoqUg_gHKBAsBv9qxHTZUPqVKMMAcOfZza5QmwU6G_ntSGsH0rt49usMh5BzoDVCmbutgQTB2QKbAJU9BKn74l6WYkJMYvygFAXJ-TCaQCaWoFFPy8B688fUq2aDdBYx3SbfGJmwTXdukDdp03uB1Yta6qrBeYfwtmrZtQtfXvvMYT8mR01XEs_HOyOfT48fiJV2-Pb8u7pepYRy6tMwghxypMnReWlCQM4UZywxQzkFp7UQmwDk1EMoNH-SlZSXK0jqbK85m5HK_24bmu8fYFRsfDVaVrrHpYyEkp1Tm8wG82oMmNDEGdEUb_EaHbQG02AkrRmEDeTFO9uWg4J8bDbEfVDBlzw</recordid><startdate>20050201</startdate><enddate>20050201</enddate><creator>Gregson, Nigel</creator><creator>Sparrowhawk, Keiron</creator><creator>Mauskopf, Josephine</creator><creator>Paul, John</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050201</creationdate><title>Pricing medicines: theory and practice, challenges and opportunities</title><author>Gregson, Nigel ; Sparrowhawk, Keiron ; Mauskopf, Josephine ; Paul, John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c341t-b51919e08c02bd181938e535c104418aaf6561ff808c8f418e4bd3be7bdfd9843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Costs and Cost Analysis - economics</topic><topic>Costs and Cost Analysis - methods</topic><topic>Costs and Cost Analysis - trends</topic><topic>Drug Costs - trends</topic><topic>Drug Industry - economics</topic><topic>Drug Industry - trends</topic><topic>Economics, Pharmaceutical - trends</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gregson, Nigel</creatorcontrib><creatorcontrib>Sparrowhawk, Keiron</creatorcontrib><creatorcontrib>Mauskopf, Josephine</creatorcontrib><creatorcontrib>Paul, John</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nature reviews. Drug discovery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gregson, Nigel</au><au>Sparrowhawk, Keiron</au><au>Mauskopf, Josephine</au><au>Paul, John</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pricing medicines: theory and practice, challenges and opportunities</atitle><jtitle>Nature reviews. Drug discovery</jtitle><addtitle>Nat Rev Drug Discov</addtitle><date>2005-02-01</date><risdate>2005</risdate><volume>4</volume><issue>2</issue><spage>121</spage><epage>130</epage><pages>121-130</pages><issn>1474-1776</issn><eissn>1474-1784</eissn><abstract>The pricing of medicines has become one of the most hotly debated topics of recent times, with the pharmaceutical industry seemingly being attacked from all quarters. From a company perspective, determining the price for each new product is more crucial than ever, given the present dearth of new drug introductions. But how are pricing strategies developed in practice? What is value-based pricing and how are financial models of return on investment constructed? What are the challenges faced in setting the price for a particular product, and how will scientific and environmental trends provide future pricing challenges or opportunities?</abstract><cop>England</cop><pmid>15688076</pmid><doi>10.1038/nrd1633</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1474-1776
ispartof Nature reviews. Drug discovery, 2005-02, Vol.4 (2), p.121-130
issn 1474-1776
1474-1784
language eng
recordid cdi_proquest_miscellaneous_67400792
source MEDLINE; Nature; SpringerLink Journals - AutoHoldings
subjects Costs and Cost Analysis - economics
Costs and Cost Analysis - methods
Costs and Cost Analysis - trends
Drug Costs - trends
Drug Industry - economics
Drug Industry - trends
Economics, Pharmaceutical - trends
Humans
title Pricing medicines: theory and practice, challenges and opportunities
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T10%3A21%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pricing%20medicines:%20theory%20and%20practice,%20challenges%20and%20opportunities&rft.jtitle=Nature%20reviews.%20Drug%20discovery&rft.au=Gregson,%20Nigel&rft.date=2005-02-01&rft.volume=4&rft.issue=2&rft.spage=121&rft.epage=130&rft.pages=121-130&rft.issn=1474-1776&rft.eissn=1474-1784&rft_id=info:doi/10.1038/nrd1633&rft_dat=%3Cproquest_cross%3E67400792%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67400792&rft_id=info:pmid/15688076&rfr_iscdi=true